Walter Reed-developed Zika vaccine induces strong immune response in three phase 1 studies

Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response. Initial findings from the trials were published today in The Lancet. Each of the three studies included in the paper was designed to address a ["]

The post Walter Reed-developed Zika vaccine induces strong immune response in three phase 1 studies appeared first on Outbreak News Today.